Home › Research › TREM2 and immune genetics
Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction
Bandyopadhyay S.. Frontiers in aging neuroscience, 2021-06-15
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Amyloidogenicity and vascular dysfunction are the key players in the pathogenesis of Alzheimer's disease (AD), involving dysregulated cellular interactions. An intricate balance between neurons, astrocytes, microglia, oligodendrocytes and vascular cells sustains the normal neuronal circuits. Conversely, cerebrovascular diseases overlap neuropathologically with AD, and glial dyshomeostasis promotes AD-associated neurodegenerative cascade.
What this study adds
Evidence grade: Low
This review describes how the balance between neurons, astrocytes, microglia, oligodendrocytes and vascular cells sustains normal neuronal circuits, and how glial dyshomeostasis promotes the Alzheimer's-associated neurodegenerative cascade. It also notes that cerebrovascular diseases overlap neuropathologically with Alzheimer's disease, suggesting that vascular dysfunction is a key player in its pathogenesis.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Bandyopadhyay, S. (2021). Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction. Frontiers in aging neuroscience. https://doi.org/10.3389/fnagi.2021.653334
Vancouver
Bandyopadhyay S. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction. Frontiers in aging neuroscience. 2021. doi:10.3389/fnagi.2021.653334. PMID: 34211387.
BibTeX
@article{bandyopadhyay2021-34211387,
author = {Bandyopadhyay, S.},
title = {{Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction}},
journal = {Frontiers in aging neuroscience},
year = {2021},
doi = {10.3389/fnagi.2021.653334},
pmid = {34211387},
url = {https://doi.org/10.3389/fnagi.2021.653334}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- An intricate balance between neurons, astrocytes, microglia, oligodendrocytes and vascular cells sustains the normal neuronal circuits.
- Conversely, cerebrovascular diseases overlap neuropathologically with AD, and glial dyshomeostasis promotes AD-associated neurodegenerative cascade.
- While pathological hallmarks of AD primarily include amyloid-β (Aβ) plaques and neurofibrillary tangles, microvascular disorders, altered cerebral blood flow (CBF), and blood-brain barrier (BBB) permeability induce neuronal loss and synaptic atrophy.
- Accordingly, microglia-mediated inflammation and astrogliosis disrupt the homeostasis of the neuro-vascular unit and stimulate infiltration of circulating leukocytes into the brain.
Why it matters
This review describes how the balance between neurons, astrocytes, microglia, oligodendrocytes and vascular cells sustains normal neuronal circuits, and how glial dyshomeostasis promotes the Alzheimer's-associated neurodegenerative cascade. It also notes that cerebrovascular diseases overlap neuropathologically with Alzheimer's disease, suggesting that vascular dysfunction is a key player in its pathogenesis.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in aging neuroscience) |
| Journal's citation record | 2 / 4 | Frontiers in Aging Neuroscience: journal h-index 174 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 62 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.9 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 3 / 6 | Cited 3.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 31 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Sanghamitra Bandyopadhyay: h-index 34 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Academy of Scientific and Innovative Research: institution h-index 324 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 34211387) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fnagi.2021.653334
- PubMed: 34211387
- Original source →
- Free full text: Frontiers in Aging Neuroscience →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 45.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in TREM2 and immune genetics from nearby years
Also in TREM2 and immune genetics
83 studies in the library are filed under TREM2 and immune genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The TREM2 and immune genetics hub.